Abstract: Renealmia alpinia is a medicinal plant that has been cultivated and used for the treatment of headaches, abdominal pain, as a febrifuge and to treat snake bites in southeast Colombia and in the Caribbean islands. Moreover, its edible fruits are commonly used as spice in Mexico. The R. alpinia leave-extracts have shown enzymatic inhibition of Bothrops atrox and Bothrops asper snake poison. The extracts also showed effects as a peripheral analgesic agent. This report investigates the analgesic activity of the essential oils obtained by hydrodistillation from wild and in vitro propagation samples of R. alpinia as well as the chemical profile using GC-MS. The essential oils isolated from R. alpinia evaluated on concentrations of 50, 75 and 100 mg/kg showed significant antinociceptive effects in the test of acetic-acid-induced abdominal writhing, compared to the control animals. The essential oil of the wild flora leaves showed the highest percentage of pain inhibition by 200 mg/kg, concluding that the essential oil of R. alpinia presents antinociceptive activity in an in vivo model. These results help us to understand the traditional use of R. alpinia to treat pain and make it a potential source for the development of phytopharmaceutics. .
Introduction
Pain is one of the health problems that most affects the quality of people's lives, which produces a significant economic and social burden [1] . According to the Colombian Association for the study of Pain, 70% of the Colombian population has suffered some sort of pain during the last six months (acute and chronic), 47% for chronic pain (64.5% of musculoskeletal type -in lower limbs and back, 23% of craniofacial type, and 7.8% of abdominal pain) and between severe and moderate intensity (41.0% and 39.0%, respectively) [2] . Phytotherapy is an important alternative for the treatment of pain because it is accessible to wide range of the population, covering the needs of primary care in health [3, 4] in developing countries and also in developed countries such as Italy, Germany and France, as an alternative or complementary therapy [3, 5] . The motivations for the use of medicinal plants as therapy for the treatment of pain result from disappointment with conventional therapies, due in many cases to their lack of effectiveness, as well as fear of the adverse/side effects of the drugs especially non-steroidal anti-inflammatory drugs (NSAIDs) [6, 7] .
Some extracts and essential oils from plants of the Zingiberaceae family have shown to be active in the treatment of pain [8] [9] [10] . This is particularly prevalent in southeast Colombia where indigenous natives use R. alpinia in the treatment of bites by poisonous snakes [11] . This plant has also been used in other countries in the Americas for the treatment of headache [12] and stomach pain [13] , among others maladies. Moreover, the fruits and leaves of R. alpinia play an important role as a spice in some regions of Mexico. In fact, the aril of the fruits is used to enhance flavor in tortillas, and their leaves are used as wrapping for different kinds of food [14, 15] . Our studies have shown that rhizomes and leaf extracts of R. alpinia inhibit the toxic and lethal effects of the poisonous venom of the Bothrops atrox and B. asper [16] [17] [18] . We also found that the main bioactive component of the dichloromethane extract is the flavanone pinostrobin that has the inhibitory capacity of the coagulant, proteolytic, hemolytic and hemorrhagic effects of B. atrox-B. asper poison [18] . Moreover, some isolated R. alpinia pure compounds were evaluated through the Siegmund test to assess activity on the peripheral nervous system [18] in animal models.
The objective of this research is the evaluation of the analgesic activity of two R. alpinia essential oils obtained from leaves of wild and micropropagated plant samples. In addition, a comparative chemical analysis of the essential oils was carried out by gas-chromatography massspectroscopy (GC-MS).
Materials and Methods

Plant Material
The leaves of R. alpinia (Rottb.) Maas obtained from wild flora were collected in Dantas village, located in the municipality of San Rafael, latitude 06° 118' N 75° 101' W (Antioquia-Colombia). It was identified and authenticated at the Herbarium of the University of Antioquia (HUA) and assigned a voucher number 176395.
In vitro culture of R. alpinia was obtained from three hundred and sixty (360) seedlings collected in the village of Titumate, Unguía, (5 m.a.s.l, Chocó, Colombia). It germinated in a room at the biological station of the University of Antioquia, and was identified in the HUA. The seedlings were washed once with iodine soap and running water, disinfected through exposure to sodium hypochlorite (NaClO) (2 %, 25 min), then transferred aseptically to culture vials with a nutrient medium previously sterilized by moist heat (121 °C). The environment is made up of basic salts of Murashige and Skoog [19, 20] , pH = 5.8, sucrose (30 g/L) and agar (7 g/L). Once established, the micropropagated seedlings were subjected to subculture every four weeks, kept at a controlled temperature (25 °C) and photoperiod of 1 day (16 h of light, 50 mol m -2 s -1 ). Both the wild plant material and micropropagated plants were dried at 38° C for 4 h and then pulverized in a mill (Covenant Electro motor RPM 50 Hz) after which they were deposited and stored in airtight containers in a cool, dry place and protected until usage.
Extraction of Essential Oils
To obtain the essential oils of wild R. alpinia (EORaw) and in vitro culture (EORaiv), the following methodology was carried out: the plant materials underwent hydrodistillation in a Clevenger-type device, with recirculation, refrigerated water and temperature control until depleting extraction (2 h, boiling temperature); 180 g of wild plant material and 90 g of plant material of culture in vitro were used, obtaining yields of 0.07 % and 0.04 % respectively; the collected essential oils were dried by adding sodium anhydrous sulfate, packed in glass bottles and stored under refrigeration (4 °C); the vials were protected from light and humidity until usage.
Experimental Animals
Swiss mice (males and females) with a weight of 23 ± 1 g were used, supplied by the animal facility of the University of Antioquia. The animals were previously housed at room temperature (22 ± 1 °C) relative humidity of 50-60 % and 12 h of light-dark cycles with food and free access to water. Two days prior to the experiment, the mice were allowed to adapt to the environment. The animals were treated under the standards of care for experimental animals of the Canadian Council for the Protection of Animals, with the endorsement of the Ethics Committee for the Experimentation with Animals of the University of Antioquia, Act No. 65/2010, and in accordance with law 84 of 1989 of the Congress of Colombia.
Analgesic Activity
In order to evaluate the analgesic activity, the following method was developed [21] : mice were randomly separated into seven groups (4 animals per group), then administered orally with the negative control group receiving vehicle (Tween 80, 5%) and the positive control group receiving ibuprofen 75 mg/kg (PBS, pH 7.2 buffer solution). The five remaining groups received doses of essential oil of wild and in vitro culture R. alpinia, of 50, 100 and 200 mg/kg for EORaw, and 50 and 100 mg/kg for EORaiv. After 30 minutes, all of the mice received an intraperitoneal injection of phenylquinone (4 mg/kg). 5 min later, the mice were placed in individual boxes for observation and the number of back-abdominal stretches were determined as evidence of visceral pain for a period of 15 min. Mice with a decrease in the number of twists were protected by the respective dose of essential oil. The percentage of inhibition of pain was calculated by the formula:
% I= Gc -Gt/Gc * 100 Where Gc is the average of the negative control group stretches and Gt is an average of stretches of the treated group.
Statistical Analysis
The results were expressed as the values of the mean ± SEM of measurements in each group. A comparison of the groups was performed using an analysis of variance (ANOVA) one-way with Dunnett's test post hoc. A p-value p<0,05 criterion of statistical significance was applied. The GraphPad Prism® software for statistical analysis was used.
GC/MS Analysis
The chemical analysis of the essential oils was performed by gas chromatography-mass spectrophotometry (GC-MS) on a 
Results and Discussion
Analgesic activity
Mice treated with EORaw and EORaiv in doses of 50, 100, 200 mg/kg, and 50 and 100 mg/kg respectively, experienced a significant reduction in stretching, compared with the negative control group, with higher doses having greater effect. The highest percentage of inhibition of pain presented itself in the EORaw 200 mg/kg (92.0%). Detailed information on the effect of essential oils on phenylquinone-induced stretches is shown in table 1. Table 1 revealed that the essential oils obtained from wild flora are more potent than the in vitro cultured. For example, with a 100 mg/kg dose, the essential oil sample from wild flora showed an inhibition percentage of 88.5 %, greater than the essential oil of cultivation in vitro, which was 79.2 %, with comparable data of the positive control ibuprofen at 75 mg/kg dose 84.0 %.
We showed that oral administration of both essential oils of R. alpinia wild and micropropagated at doses of 50, 100 and 200 mg/kg produced significant dose-dependent inhibition against the chemical induced nociception test model (Table 1) . Terpenes, the main constituents of R. alpinia essential oils showed interesting results that confirm its analgesic and anti-inflammatory activity [23] . Fonseca et al, showed that nerolidol has effects in chemical nociception models and demonstrated that the analgesic activity is mediated by the peripheral nervous system and not by the central nervous system, conducting experiments for both cases and that activity is related to the GABAergic system [24] . In addition, according to Chavan [25] , the caryophyllene oxide, which is the second most important component in EORaiv, possesses some antinociceptive properties that have demonstrated centrally and peripherally mediated analgesia by caryophyllene oxide. Based on the above, it is possible to suggest that the higher percentage of trans-Nerolidol and caryophyllene/caryophyllene oxide can be considered as responsible for the antinociceptive activity of R. alpinia essential oils.
Phenylquinone induced writhing test in mice is used to screen and study compounds for peripherally mediated analgesic activity. Peritoneal administration of phenylquinone induces endogenous pain mediators such as prostaglandins, histamine, serotonin (5-HT) and bradykinin that sensitize pain nerve endings. The released prostaglandins, mainly prostacyclin (PGI2) and to lesser extent PGE2 and PGF2α have been held responsible for pain sensation. Our results highlight the important role of analgesic activity with a mechanism of action that could be similar to ibuprofen, which prevents the synthesis of prostaglandins through inhibition of the enzyme cyclooxygenase 1 and 2 (COX1, COX2). Consequently, this brings about a decrease in the formation of precursors of prostaglandins and thromboxanes, resulting in an obvious pain decrease. We suggest that the R. alpinia essential oils carry a significant peripherally mediated analgesic [26, 27] .
Chemical analysis of the Essential Oils
The quantitative analysis of the chemical profiles of essential oils from R. alpinia is shown in Table 2 . The table includes a class of secondary metabolites (constituent), retention index, area in both essential oils from wild and in vitro grown R. alpinia and the percentage of the components identified. Fifteen compounds were identified from in vitro plants and twelve from the essential oil of the wild plants, which consist primarily of monoterpenes and sesquiterpenes. The results are shown in table 2. Essential oils are a group of secondary metabolites that currently have a productive significance [31] . Many of them are valued for their qualities as potential medicinal products [32] and cosmetics [33] . In this study, the use of two chromatographic columns was fundamental, one with polar characteristics (Carbowax 20M®), and the other with apolar characteristics (DB -5ms®), since they complemented the research well, generating confidence in the results obtained. A hydrodistillation method was employed for the extraction of volatiles from vegetal material (micropropagated and wild), using short times (90-180 m), controlled temperature (water recirculation at 4 ºC) and scarce loss of compounds that grant product aroma and biofunctionality. Table 2 shows that the essential oil of wild samples contains greater wealth from the chemical point of view than the essential oil of in vitro culture revealing substantial differences in the chemical composition. Although, the main component in both essential oils is trans-nerolidol, its percentage in EORaw (40.9 %) is almost 9 % more than in the oil of the micropropagated plant (32 %) ( Table 2 ). In addition, the second main component found in wild R. alpinia is the α-pinene (31.4 %) while in the micropropagated plant this compound only represents 1 %. On the other hand, for the micropropagated plant, we identified caryophyllene oxide as the second most abundant component (15.9 %), while in the wild plant this compound only represents 2.5 % of its composition. In general, the analysis of the R. alpinia essential oils derived from the identification of sixteen compounds. Four of them were not reported before for this botanical species (dihydroedulan II, β-elemene, farnesyl methyl ester and valencene). Our results are in accordance with previous reports for Renealmia genus essential oils, where terpenes are the main components [34, 35] . The difference in the composition can be attributed to the development conditions of the plants. Abiotic factors such as humidity, temperature, pH and soil nutrients create environmental stress on the plant and this is likely to result in production of additional secondary metabolites. Besides, the plants exposed to abiotic stimulus with which they have coevolved, also promote the development of different biosynthetic pathways through which a large variety of secondary metabolites are biosynthesized [36, 37] .
In summary, our results contribute to the knowledge on the use of this medicinal plant. The findings demonstrate that the essential oil of R. alpinia presents analgesic activity with significant results on an in vivo model. This is the first time that the R. alpinia essential oils were studied in relation to their in vivo antinociceptive activity. Future studies are underway to identify its mechanism of analgesic action. These results suggested the potential feasibility of R. alpinia as a food ingredient, as well as their possible applications in the pharmaceutical industry.
